Back to News
Market Impact: 0.6

A SpaceX IPO Could Open the Door for More Investment Into Smaller Space Companies Like Rocket Lab and Planet Labs

TNVDAINTCNFLX
IPOs & SPACsPrivate Markets & VentureInvestor Sentiment & PositioningTechnology & InnovationM&A & RestructuringCompany Fundamentals

SpaceX is expected to file for an IPO that could raise up to $75 billion and value the company at about $1.75 trillion, an event likely to increase investor attention on public space names. EchoStar (SATS) could be a direct beneficiary—it received a 2% equity stake tied to a $17–$20 billion spectrum sale to SpaceX (position worth roughly $11B under one implied valuation) and has completed other spectrum deals including a $22.6B sale to AT&T; EchoStar shares are up ~52% over the past six months. Smaller public space plays such as AST SpaceMobile (ASTS) and Rocket Lab (RKLB) could see bullish spillover and rapid price discovery post-IPO.

Analysis

A large, headline private-to-public transaction in the space ecosystem will act less as an earnings catalyst and more as a reclassification event: capital that previously sat in illiquid private positions will create a new public price anchor and trigger fresh analyst coverage, ETF creations and retail flows. Expect the biggest moves not in the issuer but among small‑float suppliers and spectrum/launch pure‑plays where incremental attention compounds liquidity-driven multiple expansion; a conservative working range is a 30–80% re‑rating in mid/small‑cap names over 3–12 months if flows concentrate. Second‑order competitive effects are asymmetric. Suppliers of rad-hard chips, RF front‑ends and ground‑station infrastructure will see order‑book optionality that is realizable only through multi‑year contracts, so their public valuations can rerate earlier than cash flows justify — creating merger arbitrage / takeout optionality for larger industrials and telcos. Conversely, incumbent terrestrial carriers that view satellite capacity as competitive leverage gain optional balance sheet optionality to pursue buybacks or spectrum swaps; regulatory approvals and integration timelines remain the gating factors that will determine who actually monetizes that optionality. Tail risks and timing: price discovery will be concentrated in the first 1–8 weeks after the benchmark deal’s pricing and again at the end of lock‑up windows; expect IV spikes and asymmetric skew. Reversal catalysts include a disappointing IPO valuation, cross‑border regulatory pushback on spectrum transfers, or a secular decline in launch cadence; these can compress multiples back into the pre‑event baseline within 3–6 months. The consensus underestimates short‑term liquidity dynamics — the correct tactical posture is event‑driven, not buy‑and‑hold sector exposure; trade around lockups, analyst coverage initiations and reported contract wins.